Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andras Perl

Showing results (1-10 of 149) with videos related to

Pageof 15
Sort By:
Autoimmunity|December 18, 2009
Pathogenic mechanisms in systemic lupus erythematosusAndras Perl
Autoimmunity|December 17, 2009
Systems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatmentAndras Perl
Methods in Molecular Medicine|August 3, 2004
Pathogenesis and spectrum of autoimmunityAndras Perl
IUBMB Life|July 7, 2007
The pathogenesis of transaldolase deficiencyAndras Perl
Annals of the New York Academy of Sciences|April 25, 2015
mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and agingAndras Perl
Clinical Immunology (Orlando, Fla.)|January 17, 2012
Oxidative stress and endosome recycling are complementary mechanisms reorganizing the T-cell receptor signaling complex in SLEAndras Perl
Nature Reviews. Rheumatology|December 25, 2015
Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseasesAndras Perl
Rheumatic Diseases Clinics of North America|March 15, 2003
Role of endogenous retroviruses in autoimmune diseasesAndras Perl
Arthritis & Rheumatology (Hoboken, N.J.)|August 26, 2017
Review: Metabolic Control of Immune System Activation in Rheumatic DiseasesAndras Perl
Arthritis & Rheumatology (Hoboken, N.J.)|June 25, 2016
Editorial: LINEing Up to Boost Interferon Production: Activation of Endogenous Retroviral DNA in AutoimmunityAndras Perl
Pageof 15

Showing results (1-10 of 149) with videos related to

Sort By:
Pageof 15
Autoimmunity|December 18, 2009
Pathogenic mechanisms in systemic lupus erythematosusAndras Perl
Autoimmunity|December 17, 2009
Systems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatmentAndras Perl
Methods in Molecular Medicine|August 3, 2004
Pathogenesis and spectrum of autoimmunityAndras Perl
IUBMB Life|July 7, 2007
The pathogenesis of transaldolase deficiencyAndras Perl
Annals of the New York Academy of Sciences|April 25, 2015
mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and agingAndras Perl
Clinical Immunology (Orlando, Fla.)|January 17, 2012
Oxidative stress and endosome recycling are complementary mechanisms reorganizing the T-cell receptor signaling complex in SLEAndras Perl
Nature Reviews. Rheumatology|December 25, 2015
Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseasesAndras Perl
Rheumatic Diseases Clinics of North America|March 15, 2003
Role of endogenous retroviruses in autoimmune diseasesAndras Perl
Arthritis & Rheumatology (Hoboken, N.J.)|August 26, 2017
Review: Metabolic Control of Immune System Activation in Rheumatic DiseasesAndras Perl
Arthritis & Rheumatology (Hoboken, N.J.)|June 25, 2016
Editorial: LINEing Up to Boost Interferon Production: Activation of Endogenous Retroviral DNA in AutoimmunityAndras Perl
Pageof 15